These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 38409

  • 1. Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain.
    Quik M, Emson PC, Fahrenkrug J, Iversen LL.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):281-6. PubMed ID: 38409
    [Abstract] [Full Text] [Related]

  • 2. A long ascending projection in the rat brain containing vasoactive intestinal polypeptide.
    Marley PD, Emson PC, Hunt SP, Fahrenkrug J.
    Neurosci Lett; 1981 Dec 23; 27(3):261-6. PubMed ID: 6120491
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons.
    Kerwin RW, Pay S, Bhoola KD, Pycock CJ.
    J Pharm Pharmacol; 1980 Aug 23; 32(8):561-6. PubMed ID: 6106694
    [Abstract] [Full Text] [Related]

  • 4. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
    Minneman KP, Quik M, Emson PC.
    Brain Res; 1978 Aug 11; 151(3):507-21. PubMed ID: 27287
    [Abstract] [Full Text] [Related]

  • 5. Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.
    Quik M, Iversen LL, Bloom SR.
    Biochem Pharmacol; 1978 Aug 11; 27(18):2209-13. PubMed ID: 83146
    [No Abstract] [Full Text] [Related]

  • 6. Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP accumulation in brain slices [proceedings].
    Bloom S, Iversen LL, Quik M.
    Br J Pharmacol; 1978 Mar 11; 62(3):435P. PubMed ID: 205298
    [No Abstract] [Full Text] [Related]

  • 7. GABAB receptor-mediated enhancement of vasoactive intestinal peptide-stimulated cyclic AMP production in slices of rat cerebral cortex.
    Watling KJ, Bristow DR.
    J Neurochem; 1986 Jun 11; 46(6):1755-62. PubMed ID: 3009716
    [Abstract] [Full Text] [Related]

  • 8. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R, Simonton S, Coyle JT.
    J Neuropathol Exp Neurol; 1980 May 11; 39(3):245-64. PubMed ID: 6154134
    [Abstract] [Full Text] [Related]

  • 9. VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis.
    Roberts GW, Woodhams PL, Bryant MG, Crow TJ, Bloom SR, Polak JM.
    Histochemistry; 1980 Feb 11; 65(2):103-19. PubMed ID: 7358518
    [Abstract] [Full Text] [Related]

  • 10. Properties and distribution of vasoactive intestinal polypeptide receptors in the rat brain.
    Ogawa N, Mizuno S, Mori A, Nukina I, Yanaihara N.
    Peptides; 1985 Feb 11; 6 Suppl 1():103-9. PubMed ID: 2995938
    [Abstract] [Full Text] [Related]

  • 11. Calcium dependence of vasoactive intestinal peptide-stimulated cyclic AMP accumulation in rat hippocampal slices.
    Etgen AM, Browning ET.
    J Neurochem; 1987 Jul 11; 49(1):303-9. PubMed ID: 2438383
    [Abstract] [Full Text] [Related]

  • 12. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL, Rouyer-Fessard C, Balasubramaniam A, Saint Pierre S, Laburthe M.
    Endocrinology; 1989 Feb 11; 124(2):692-700. PubMed ID: 2536315
    [Abstract] [Full Text] [Related]

  • 13. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
    Friedle NM, Kelly PH, Moore KE.
    Br J Pharmacol; 1978 May 11; 63(1):151-8. PubMed ID: 148306
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the action of cholecystokinin, carbachol and vasoactive intestinal peptide on receptor-activated formation of cyclic GMP and cyclic AMP in the striatum and the pancreas.
    O'Shaughnessy C, Bhoola KD.
    Biochem Pharmacol; 1986 Nov 15; 35(22):4049-52. PubMed ID: 3022747
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.
    Epelbaum J, Tapia-Arancibia L, Besson J, Rotsztejn WH, Kordon C.
    Eur J Pharmacol; 1979 Oct 15; 58(4):493-5. PubMed ID: 510382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.